Craig A. Johnson, Director at Mirati Therapeutics, Inc. (MRTX), sold 25,475 shares at $61.80 ($1.6M) on 2019-01-29, disclosed to the SEC on 2019-01-31.
Open-market sale of $1.6M MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.11 | 8,475 | $518K | 33.1% |
| 2 | $61.11 | 8,475 | $518K | 33.1% |
| 3 | $61.80 | 8,525 | $527K | 33.7% |
| Total | $61.34 avg | 25,475 | $1.6M | 100% |
| Filing → |
| HRTX | SELL | 2021-06-22 | $4K | — | Filing → |
| HRTX | SELL | 2021-04-07 | $4K | — | Filing → |
| MRTX | SELL | 2021-01-25 | $6.3M | — | Filing → |